Laboratory Products

  • New Antibodies for COVID-19 vVrus Detection

New Antibodies for COVID-19 vVrus Detection

Aug 12 2020 Read 216 Times

The nucleocapsid of COVID-19 virus is ideal for antigen detection for two major reasons:

1) It is produced abundantly in infected cells.

2) It is a highly conserved protein and therefore not prone to mutation.

The cytoplasm of infected cells fills with the nucleocapsid antigen. These cells can be collected on a NP swab and added to a specimen buffer to lyse and release this antigen for detection by immunoassay.

ViroStat has developed and just released a set of new monoclonal antibodies to the nucleocapsid of the COVID-19 virus. These final 5 antibodies were selected from an initial group of 60 based upon highest binding affinity and best ELISA pairing for detection of native viral antigen.

Download the data sheet for these new monoclonal antibodies. 

More information online

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment

Digital Edition

LabAsia Buyers Guide 2020

October 2020

In This Edition Articles - Ambient Ionisation MS and GC-MS Analysis and Identification of Aroma Compounds in Agave Based Alcoholic Beverages - How a Chromatographic Method is More Than a Sep...

View all digital editions


West Africa Water Expo

Oct 06 2020 Lagos, Nigeria


Oct 06 2020 Digital Forum


Oct 07 2020 Lyon, France


Oct 07 2020 Lausanne, Switzerland

View all events